SEBASTIANI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 7.930
EU - Europa 5.996
AS - Asia 2.838
SA - Sud America 422
Continente sconosciuto - Info sul continente non disponibili 303
AF - Africa 169
OC - Oceania 22
Totale 17.680
Nazione #
US - Stati Uniti d'America 7.813
IT - Italia 1.535
RU - Federazione Russa 1.174
GB - Regno Unito 1.082
SG - Singapore 894
CN - Cina 868
IE - Irlanda 692
BR - Brasile 339
SE - Svezia 328
VN - Vietnam 326
HK - Hong Kong 255
FR - Francia 245
UA - Ucraina 242
DE - Germania 213
FI - Finlandia 167
KR - Corea 120
IN - India 98
ZA - Sudafrica 95
ES - Italia 81
CA - Canada 59
BD - Bangladesh 54
NL - Olanda 54
BE - Belgio 53
PK - Pakistan 41
TR - Turchia 38
MX - Messico 34
PL - Polonia 27
JP - Giappone 25
IQ - Iraq 22
AU - Australia 21
AR - Argentina 18
AT - Austria 17
NG - Nigeria 17
CZ - Repubblica Ceca 16
VE - Venezuela 15
EC - Ecuador 14
CO - Colombia 13
IR - Iran 12
SA - Arabia Saudita 12
EG - Egitto 11
JO - Giordania 11
MA - Marocco 11
CI - Costa d'Avorio 10
GR - Grecia 10
LT - Lituania 10
KE - Kenya 9
IL - Israele 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
CH - Svizzera 5
DZ - Algeria 5
KG - Kirghizistan 5
MY - Malesia 5
PH - Filippine 5
RO - Romania 5
BY - Bielorussia 4
CR - Costa Rica 4
DK - Danimarca 4
ID - Indonesia 4
JM - Giamaica 4
LU - Lussemburgo 4
PE - Perù 4
PT - Portogallo 4
PY - Paraguay 4
UY - Uruguay 4
UZ - Uzbekistan 4
BO - Bolivia 3
ET - Etiopia 3
HU - Ungheria 3
LV - Lettonia 3
SN - Senegal 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
EE - Estonia 2
HN - Honduras 2
IM - Isola di Man 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
DM - Dominica 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
Totale 17.362
Città #
Dallas 1.769
Southend 930
Dublin 685
Fairfield 674
Ashburn 631
Singapore 505
San Jose 372
Santa Clara 353
Milan 339
Moscow 331
Chandler 318
Woodbridge 275
Siena 270
Houston 268
Hong Kong 242
Beijing 240
Cambridge 228
Council Bluffs 212
Wilmington 208
Seattle 203
Jacksonville 188
Hefei 162
New York 157
Ann Arbor 153
Los Angeles 116
Seoul 116
The Dalles 114
Rome 107
Princeton 100
Helsinki 95
Florence 91
Johannesburg 90
Ho Chi Minh City 87
Lauterbourg 82
Nanjing 76
Munich 65
Dong Ket 64
Hanoi 58
Málaga 51
Shanghai 47
Buffalo 40
Columbus 39
San Diego 39
Boardman 35
São Paulo 33
London 30
San Mateo 28
Chicago 27
Frankfurt am Main 27
Phoenix 27
Orem 26
Turku 26
Brussels 24
Warsaw 22
Chennai 21
Nuremberg 21
Bengaluru 20
Figino 20
Montreal 20
Turin 20
Dearborn 19
Fremont 19
Redondo Beach 19
Washington 19
Da Nang 18
Nanchang 18
Lappeenranta 17
Brooklyn 16
Leuven 16
Abuja 15
Changsha 15
Atlanta 14
Düsseldorf 14
Naples 14
Portsmouth 14
Tokyo 14
Zhengzhou 14
Amsterdam 13
Mumbai 13
Pisa 13
Brno 12
Dhaka 12
Izmir 12
Karachi 12
Lahore 12
Manchester 12
Toronto 12
Verona 12
Amman 11
City of London 11
Denver 11
Jiaxing 11
Redwood City 11
San Francisco 11
Abidjan 10
Biên Hòa 10
Bologna 10
Boston 10
Hebei 10
Istanbul 10
Totale 12.153
Nome #
Comprehensive sequencing profile and functional analysis of IsomiRs in human pancreatic islets and beta cells 1.276
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 339
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes 331
Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells 314
Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? 311
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 309
From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage 308
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes 306
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism 304
Lymphocyte-derived exosomal microRNAs promote pancreatic β-cell death and may contribute to type 1 diabetes development. 301
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 299
Circulating microRNA (miRNA) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of miRNA miR-330-3p 299
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes 297
Circulating MicroRNAs as biomarkers of gestational diabetes mellitus: Updates and perspectives 295
A plasma miR-193b-365 signature combined with age and glycemic status predicts response to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes 284
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression 284
MicroRNA expression analysis of in vitro dedifferentiated human pancreatic islet cells reveals the activation of the pluripotency-related microRNA cluster miR-302s 272
Islet-reactive CD8+T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors 272
MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients 268
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells 267
Prognostic bioindicators in severe COVID-19 patients 259
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 253
Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors 253
MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications 251
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes 250
Delta-cell specific expression of Hedgehog pathway Ptch1 receptor in murine and human endocrine pancreas 249
A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes 244
MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p regulate the expression of proapoptotic bh3-only proteins DP5 and PUMA in human pancreatic β-cells 238
A three-layer perspective on miRNA regulation in β cell inflammation 236
The Landscape of microRNAs in βCell: between phenotype maintenance and protection 229
Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells 228
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 226
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 225
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes 225
MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion 224
Coxsackieviruses and Insulitis 222
Oral delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. 220
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside 214
Multi-Omics Integrative Approach of Extracellular Vesicles: A Future Challenging Milestone 212
Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells 211
Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes 210
Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors 209
Non-coding RNAs: novel players in insulin resistance and related diseases 209
MicroRNA circolanti come biomarcatori per il diabete mellito di tipo 2: avanzamenti e prospettive future 207
Circulating microRNAs signature for predicting response to GLP1-RA therapy in Type 2 diabetic patients: a pilot study 206
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment 202
Increased Expression of Viral Sensor MDA5 in Pancreatic Islets and in Hormone-Negative Endocrine Cells in Recent Onset Type 1 Diabetic Donors 197
Viral Infections and diabetes 196
SARS-CoV-2 receptor Angiotensin I-Converting Enzyme type 2 (ACE2) is expressed in human pancreatic β-cells and in the human pancreas microvasculature 196
MicroRNAs as new tools for exploring type 1 diabetes: relevance for immunomodulation and transplantation therapy 193
Dietary supplementation with high doses of regular vitamin D3 safely reduces Diabetes incidence in nod mice when given early and long-term. 192
The case for virus-induced type 1 diabetes 190
Virus infections: lessons from pancreas histology 189
Microbioma intestinale e diabete mellito 188
Reduced miR-184-3p expression protects pancreatic β-cells from lipotoxic and proinflammatory apoptosis in type 2 diabetes via CRTC1 upregulation 186
Enteroviral Infections and Development of Type 1 Diabetes: The Brothers Karamazov Within the CVBs 185
Common molecular pathways targeted by nintedanib in cancer and IPF: a bioinformatic study 184
Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity 178
Immunology in the clinic review series; focus on type 1 diabetes and viruses: how viral infections modulate beta cell function 175
Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic Homeostasis 174
Protocol to analyze circulating small non-coding RNAs by high-throughput RNA sequencing from human plasma samples 152
NF-κB-inducing kinase (NIK) is activated in pancreatic β-cells but does not contribute to the development of diabetes 152
Pancreatic beta-cell IL-22 receptor deficiency induces age-dependent dysregulation of insulin biosynthesis and systemic glucose homeostasis 146
Extracellular vesicles in immune system regulation and Type 1 diabetes: cell-to-cell communication Mediators, disease biomarkers, and promising therapeutic tools 146
MicroRNAs: Novel players in the dialogue between pancreatic islets and immune system in autoimmune diabetes 142
Multi‐omics analysis reveals drivers of loss of β‐cell function after newly diagnosed autoimmune type 1 diabetes: An INNODIA multicenter study 141
Micro-RNA expression profiling in Paget's disease of bone 135
CD8+ T Cells Variably Recognize Native Versus Citrullinated GRP78 Epitopes in Type 1 Diabetes 131
Maternal gluten, cereal, and dietary fiber intake during pregnancy and lactation and the risk of islet autoimmunity and type 1 diabetes in the child 130
Immunoregulated insulitis and slow-progressing type 1 diabetes after duodenopancreatectomy 130
null 128
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells 120
Intestinal Delivery of Proinsulin and IL-10 via Lactococcus lactis Combined With Low-Dose Anti-CD3 Restores Tolerance Outside the Window of Acute Type 1 Diabetes Diagnosis 114
null 106
null 90
Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes 87
Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo 80
null 79
Totale 17.680
Categoria #
all - tutte 51.862
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.862


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022710 0 0 61 100 39 31 39 30 38 78 113 181
2022/20231.318 72 133 134 158 140 281 31 85 108 66 62 48
2023/20241.243 39 49 111 74 58 340 375 39 6 62 15 75
2024/20252.415 49 128 276 148 314 153 108 138 230 111 229 531
2025/20266.859 429 696 1.674 685 1.091 185 668 204 237 364 196 430
2026/2027607 290 166 151 0 0 0 0 0 0 0 0 0
Totale 17.680